Missing part of the picture?
As a pharmacist, you play an important role in counselling diabetes patients. The Dexcom G7 Continuous Glucose Monitoring (CGM) System helps your patients access continuous and accurate glucose readings, filling critical gaps.
How does Dexcom G7
help you to make a difference?
Better Clinical Outcomes
In studies, consistent use of Dexcom G7 correlates with reduced HbA1c levels1-5 and fewer hypoglycemic episodes6.
Proven
Protection
The Urgent Low Soon alert can reduce time spent in hypoglycemia by nearly 50%.7
Improved
Quality of Life
Reduced fear of hypoglycemia8 and confident diabetes management for your patients.
More
Freedom
Patients can make informed decisions about their food, activity, and insulin in real-time without the need for routine fingersticks.*
Hear directly from patients who experience the difference Dexcom G7 has made to their lives.
See the full impact through real-life patient testimonials that demonstrate the transformative power of Dexcom G7.
Request samples† today and introduce the benefits of Dexcom G7 to your patients!
The Dexcom G7 CGM System is easy to dispense, easy to start, and easy to use. It is the most accurate CGM system¶,9 for diabetes management that provides accuracy and ease of use for your patients, helping to protect them from hypoglycemia with its unique predictive Urgent Low Soon alert.
What are the key benefits
of Dexcom G7 to you, the pharmacist?
Easy
to Dispense
Physicians can e-prescribe Dexcom G7 for you through most EMRs and the ordering workflow is simple.
Counselling
Opportunities
Can provide essential data that may facilitate personalized patient counseling and improve diabetes management.
Streamlined
Replacement Process
Efficient sensor replacement reduces patient wait time and makes the process simple.
Extensive
Support Resources
Access to comprehensive training and support materials, aiding you in delivering exceptional patient care.
Recommend Dexcom G7 to your patients
on insulin and initiate a prescription!
What are the key benefits
of Dexcom G7 to your patients?
With these features, Dexcom G7 not only fills the gaps but also
enhances overall diabetes care by providing reliable, real-time insights.
Proactive Protection
Predictive Urgent Low Soon alerts will warn your patients up to 20 minutes before severe hypoglycemia strikes.
Exceptional Accuracy
A new benchmark in sensor accuracy, with an overall armwear MARD of 8.1% for pediatrics and 8.2% for adults, and 94.6% of sensor readings within 20/20% of YSI.10
Real-Time Data
Continuous glucose readings without the need for routine fingersticks or scans.*
Ease of Use
Simple and painless sensor insertion9, 30-minute sensor warm-up,10 and small, discreet design.
How can I get my patients
started with Dexcom G7?
Pharmacy Resources
More information, tools, and education that will help you support your patients today.
Insurance Coverage
Access information about insurance coverage of Dexcom G7 and about co-pay assistance for your patients.
Clinical Evidence
Review the latest clinical evidence that demonstrates the performance and benefits of Dexcom CGM systems.
The Dexcom G7 CGM System isn’t just another device.
It’s a game-changer in diabetes care for your patients!
*If glucose alerts and readings from the Dexcom G7 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
¶When compared with CGM systems commercially available in Canada as of August 2024.
†The Dexcom G7 Continuous Glucose Monitoring (“CGM”) System (“Dexcom G7”) is provided for the sole purpose of allowing a healthcare provider and patient to observe and evaluate the patient experience, including the ease of use, safety, and efficacy of the Dexcom G7 and to determine whether the Dexcom G7 is right for the patient. This sample includes one (1) Dexcom G7 sensor.
1 Beck RW, et al. JAMA. 2017;317(4):371-378.
2 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
3 Martens T, et al. JAMA. 2021;325(22):2262-2272.
4 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
5 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7.
6 Heinemann L, et al. Lancet. 2018;391(10128):1367-77.
7 Puhr S, et al. J Diabetes Sci Technol. 2020;14(1):83-86.
8 Visser MM, et al. Lancet. 2021;397(10291):2275-2283.
9 Dexcom, Data on File, 2024.
10 Dexcom G7 CGM System User Guide